Announcement of TTY Biopharm's unaudited income information in December 2020
2021.1.18
Provided by: TTY BIOPHARM COMPANY LIMITED
| SEQ_NO | 1 | Date of announcement | 2021/01/18 | Time of announcement | 17:02:26 |
| Subject | Announcement of TTY Biopharm's unaudited income information in December 2020 | ||||
| Date of events | 2021/01/18 | To which item it meets | paragraph 53 | ||
| Statement | 1.Date of occurrence of the event:2021/01/18 2.Company name:TTY Biopharm Co., Ltd. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:N/A 5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $373,446 thousands(expressed in NT dollars; unaudited), a consolidated operating profit of $79,250 thousands, and a consolidated income before tax of $74,498 thousands in December 2020; net income attributed to stockholders of the company was $56,343 thousands; EPS is $0.23. Year-to-date consolidated net sales was $4,222,212 thousands (in NT dollars; unaudited), a consolidated operating profit was $957,864 thousands and consolidated income before tax was $1,115,825 thousands until December 2020; year-to-date net income attributed to stockholders of the company was $840,069 thousands; EPS is $3.38. 6.Countermeasures:N/A 7.Any other matters that need to be specified:The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail. |
||||